CKD Pharm. which was founded in 1941 with a motto "Better life through better medicine" has been developed one of Korean representative companies. CKD newly launched novel anti-cancer drug "CAMTOBELL inj.(Belotecan)" in 2003 and will develop novel anti-diabetic drug(Lobeglitazone) in 2015.
CardioVascular Research Foundation(CVRF)
2nd Floor, Asan Institute for Education & Research,
88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea
Business registration number: 215-82-06387
Copyright ¨Ï 2002 CVRF, Seoul, Korea. All rights reserved.